Shabason, Jacob E. http://orcid.org/0000-0002-1880-1207
Chen, Jerry
Apisarnthanarax, Smith
Damjanov, Nevena
Giantonio, Bruce
Loaiza-Bonilla, Arturo
O’Dwyer, Peter J.
O’Hara, Mark
Reiss, Kim A.
Teitelbaum, Ursina
Wissel, Paul
Drebin, Jeffrey A.
Vollmer, Charles
Kochman, Michael
Mick, Rosemarie
Vergara, Norge
Jhala, Nirag
Doucette, Abigail
Lukens, John N.
Plastaras, John P.
Metz, James M.
Ben-Josef, Edgar
Funding for this research was provided by:
The Pancreatic Cancer Translational Center of Excellence at the Abramson Cancer Center.
National Institutes of Health (KL2TR001879)
Article History
Received: 18 December 2017
Accepted: 9 January 2018
First Online: 23 January 2018
Compliance with ethical standards
:
: Arturo Loaiza-Bonilla serves as a consultant at Massive Bio, Inc, and on the advisory board with Celgene, Genentech and Ipsen. Michael Kochman serves as a consultant for Olympus, BSC, Ferring, Dark Canyon Labs and his spouse is employed at Merck. Peter O’Dwyer received grant support and is on an advisory committee for Celegene. All remaining authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.